XTL BIOPHARMACEUTICALS-ADR (XTLB) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:XTLB • US98386D3070

0.8365 USD
+0 (+0.06%)
Last: Feb 3, 2026, 08:00 PM

No Analyst data available for XTLB.

Related screens

Up and Down Grades

XTL BIOPHARMACEUTICALS-ADR / XTLB FAQ